143 related articles for article (PubMed ID: 27562863)
1. The cytotoxic T cells may contribute to the in situ immune response in Jorge Lobo's Disease human lesions.
Alexandre AF; Quaresma JA; Barboza TC; de Brito AC; Xavier MB; de Oliveira CM; Unger DA; Kanashiro-Galo L; Sotto MN; Duarte MI; Pagliari C
Med Mycol; 2017 Feb; 55(2):145-149. PubMed ID: 27562863
[TBL] [Abstract][Full Text] [Related]
2. Th17 and regulatory T cells contribute to the in situ immune response in skin lesions of Jorge Lobo's disease.
Kanashiro-Galo L; Pagliari C; Barboza TC; de Brito AC; Xavier MB; de Oliveira CM; Unger DA; Sotto MN; Quaresma JA; Duarte MI
Med Mycol; 2016 Jan; 54(1):23-8. PubMed ID: 26333354
[TBL] [Abstract][Full Text] [Related]
3. Jorge Lobo's disease: immunohistochemical characterization of dendritic cells in cutaneous lesions.
Barboza TC; Quaresma JA; de Brito AC; Xavier MB; de Oliveira CM; Unger DA; Duarte MI; Sotto MN; Pagliari C
Mycopathologia; 2015 Apr; 179(3-4):269-74. PubMed ID: 25487975
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of Langerhans cells in cutaneous lesions of the Jorge Lobo's disease.
Quaresma JA; Unger D; Pagliari C; Sotto MN; Duarte MI; de Brito AC
Acta Trop; 2010 Apr; 114(1):59-62. PubMed ID: 20044969
[TBL] [Abstract][Full Text] [Related]
5. Jorge Lobo's disease.
Carvalho KA; Floriano MC; Enokihara MM; Mascarenhas MR
An Bras Dermatol; 2015; 90(4):586-8. PubMed ID: 26375233
[TBL] [Abstract][Full Text] [Related]
6. Jorge Lobo's disease with malignant degeneration to squamous cell carcinoma: case report.
de Brito AC; Bittencourt MJS; Gonçalves TDS; Cavalcante RH
An Bras Dermatol; 2022; 97(1):93-95. PubMed ID: 34836741
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical characterization of the cellular infiltrate in Jorge Lobo's disease.
Vilani-Moreno FR; Belone AF; Soares CT; Opromolla DV
Rev Iberoam Micol; 2005 Mar; 22(1):44-9. PubMed ID: 15813683
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Immune Response Markers in Jorge Lobo's Disease Lesions Suggests the Occurrence of Mixed T Helper Responses with the Dominance of Regulatory T Cell Activity.
Azevedo Mde C; Rosa PS; Soares CT; Fachin LR; Baptista IM; Woods WJ; Garlet GP; Trombone AP; Belone Ade F
PLoS One; 2015; 10(12):e0145814. PubMed ID: 26700881
[TBL] [Abstract][Full Text] [Related]
9. Analysis of microvasculature phenotype and endothelial activation markers in skin lesions of lacaziosis (Lobomycosis).
Quaresma JA; Brito MV; Sousa JR; Silva LM; Hirai KE; Araujo RS; de Brito AC; Carneiro FR; Fuzii HT; Pagliari C; Sotto MN; Duarte MI
Microb Pathog; 2015 Jan; 78():29-36. PubMed ID: 25450888
[TBL] [Abstract][Full Text] [Related]
10. Jorge Lobo's disease with restricted labial presentation.
Miranda MF; Unger DA; Brito AC; Carneiro FA
An Bras Dermatol; 2011; 86(2):373-4. PubMed ID: 21603828
[TBL] [Abstract][Full Text] [Related]
11. Disseminated infection with Lacazia loboi and immunopathology of the lesional spectrum.
Oliveira Carneiro FR; da Cunha Fischer TR; Brandão CM; Pagliari C; Duarte MI; Quaresma JA
Hum Pathol; 2015 Feb; 46(2):334-8. PubMed ID: 25532940
[TBL] [Abstract][Full Text] [Related]
12. Nutritional status and immune response in murine experimental Jorge Lobo's disease.
Barbosa AS; Diório SM; Pedrini SC; Silva SM; Sartori BG; Calvi SA; Pereira PC; Vilani-Moreno FR
Mycoses; 2015 Sep; 58(9):522-30. PubMed ID: 26156007
[TBL] [Abstract][Full Text] [Related]
13. Macrophage immunophenotypes in Jorge Lobo's disease and lepromatous leprosy- A comparative study.
Sasso BM; Vallarelli A; Rosa PS; Belone A; Velho P; Cintra ML
Microb Pathog; 2024 May; 190():106610. PubMed ID: 38484920
[TBL] [Abstract][Full Text] [Related]
14. Lacaziosis - unusual clinical presentation.
Sousa PP; Schettini AP; Rodrigues CA; Westphal DC
An Bras Dermatol; 2015; 90(2):268-9. PubMed ID: 25831004
[TBL] [Abstract][Full Text] [Related]
15. Jorge Lobo's disease: a case of keloidal blastomycosis (lobomycosis) in a nonendemic area.
Arju R; Kothadia JP; Kaminski M; Abraham S; Giashuddin S
Ther Adv Infect Dis; 2014 Jun; 2(3-4):91-6. PubMed ID: 25469235
[TBL] [Abstract][Full Text] [Related]
16. Enzymatic isolation of Lacazia loboi cells from skin lesions of lobomycosis.
Salgado CG; Tavares LS; Plautz HL; Da Silva MB; Yamano SS; Da Costa PF; Hamoy IG; Marinho AN; Santos AK; Salgado UI; Da Silva JP
Med Mycol; 2009 Mar; 47(2):119-23. PubMed ID: 18651310
[TBL] [Abstract][Full Text] [Related]
17. Macrophage and TGF-beta immunohistochemical expression in Jorge Lobo's disease.
Xavier MB; Libonati RM; Unger D; Oliveira C; Corbett CE; de Brito AC; Quaresma JA
Hum Pathol; 2008 Feb; 39(2):269-74. PubMed ID: 17959227
[TBL] [Abstract][Full Text] [Related]
18. Accidental Jorge Lobo's disease in a worker dealing with Lacazia loboi infected mice: a case report.
Rosa PS; Soares CT; Belone Ade F; Vilela R; Ura S; Filho MC; Mendoza L
J Med Case Rep; 2009 Feb; 3():67. PubMed ID: 19220901
[TBL] [Abstract][Full Text] [Related]
19. Detection of cytokines and nitric oxide synthase in skin lesions of Jorge Lobo's disease patients.
Vilani-Moreno FR; Belone Ade F; Lara VS; Venturini J; Lauris JR; Soares CT
Med Mycol; 2011 Aug; 49(6):643-8. PubMed ID: 21208026
[TBL] [Abstract][Full Text] [Related]
20. Plasmacytoid dendritic cells in cutaneous lesions of patients with chromoblastomycosis, lacaziosis, and paracoccidioidomycosis: a comparative analysis.
Pagliari C; Kanashiro-Galo L; Silva AA; Barboza TC; Criado PR; Duarte MI; Brito AC; Xavier MB; Unger D; Maria Moraes Oliveira C; Quaresma JA; Sotto MN
Med Mycol; 2014 May; 52(4):397-402. PubMed ID: 24782102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
